Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has had discussions with ministerial colleagues regarding the potential for the UK to become a global leader in AI-enabled cardiac diagnostics through partnerships with the third sector and academic institutions.

My Rt Hon. Friend, the Secretary of State for Health and Social Care, and ministers across the Government regularly engage with colleagues, the National Health Service, academia, and industry on how the United Kingdom can strengthen its position as a global leader in the safe and responsible use of artificial intelligence (AI) in healthcare.

The Government recognises the significant potential of AI‑enabled technologies, including in cardiac diagnostics, to support earlier detection, improve clinical decision‑making, and deliver better outcomes for patients. The UK already benefits from a strong life sciences ecosystem and world‑leading academic research, which play an important role in developing, evaluating, and deploying innovative diagnostic tools.

Historically through programmes such as the NHS AI Lab, and current ongoing support for health data research through partnerships with universities, charities, and industry, the Government is creating the conditions for innovation to be translated safely into clinical practice. Any adoption of AI‑enabled diagnostics in the NHS is subject to robust evaluation, regulation, and clinical oversight to ensure patient safety and effectiveness through regulatory bodies such as The Medicines and Healthcare products Regulatory Agency and the National Institute for Health and Care Excellence.